In June 2010 the Board of Directors of RVC has approved the Conceptual Framework of RVC Biofund. In early 2011, the fund started its operations. The Biofund was necessitated by a low share of Russian innovative drugs, amounting today to less than 1%. With virtually zero infrastructure to develop biopharma and medical start-ups, foreign services devour 50% to 80% of Russian investment resources. To remedy this, RVC BioFund will be investing capital into service companies of this cluster and biotech start-ups. Additionally, it will be launching an ecosystem to generate and incubate as many biotech projects as possible. The Fund focus covers innovative biopharma companies and service companies providing contract, laboratory, analytical and consulting services to biotechnological, pharmaceutical and medical companies.
| Website | http://www.rusventure.ru/ru/investments/biofund/about.php |
| Employees | 3 (3 on RocketReach) |
| Founded | 2011 |
| Phone | +1 508-647-2292 |
| Industry | Venture Capital and Private Equity Principals, Venture Investment, Biotech |
| Web Rank | 3 Million |
| Keywords | Private Equity Biotech, Biotechnology Venture Capital, Biopharmaceutical Investment, Life Sciences Investment, Pharmaceutical Funding, Innovative Drugs, Biotech Investing, Healthcare Venture Capital, Drug Development Funding, Biomedical Investment, Seed Funding Biotech, Early Stage Biotech, Venture Capital Fund, Biotech Startups, Pharmaceutical Startups, Healthcare Startups, Life Science Funding, Biotechnology Fund, Investment Fund |
Looking for a particular RVC Biofund employee's phone or email?
RVC Biofund Questions
Egor Beketov is the CEO of RVC Biofund.
3 people are employed at RVC Biofund.
Top RVC Biofund Employees
Related Companies
